Stay updated on Mirvetuximab Soravtansine Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Soravtansine Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.9%
    Check dated 2025-05-08T14:40:44.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T09:47:23.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the details of a study on mirvetuximab soravtansine (IMGN853) for ovarian cancer, including its purpose, study design, and inclusion/exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    16%
    Check dated 2025-04-17T01:43:51.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.9%
    Check dated 2025-04-09T17:45:12.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.9%
    Check dated 2025-04-02T03:22:10.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-02-25T09:43:46.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Soravtansine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Soravtansine Clinical Trial page.